National Panel of Tobacco Consumer Studies

ICR 201903-0910-010

OMB: 0910-0815

Federal Form Document

Forms and Documents
ICR Details
0910-0815 201903-0910-010
Historical Active 201802-0910-003
National Panel of Tobacco Consumer Studies
Revision of a currently approved collection   No
Approved with change 02/28/2020
Retrieve Notice of Action (NOA) 05/21/2019
Approval is given consistent with the understanding that when communicating or publishing research outcomes associated with this clearance, CTP will present: a) the unweighted distribution of sociodemographic and geographic characteristics of the sample that responded to a given survey, and b) study results based on both weighted and unweighted data. Consistent with obligations under HHS and OMB’s Information Quality Guidelines, CTP will assess the quality of the information generated by collections conducted under this OMB Control Number for each regulatory or policy purpose under consideration. This three year clearance covers only survey replenishment and studies as currently described. Additional observational studies conducted under this control number will be submitted to OMB as revisions under the PRA.
  Inventory as of this Action Requested Previously Approved
02/28/2023 36 Months From Approved 02/29/2020
15,602 0 27,935
3,340 0 4,435
0 0 0

The U. S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) proposes to established a high-quality, national panel of about 4,000 tobacco users. The panel will includes individuals who agree to participate in up to 8 experimental or observational studies over a 3-year period to assess consumers’ responses to tobacco marketing, warning statements, product labels, and other communications about tobacco products. CTP proposes the establishment of the panel of consumers because currently existing panels have a number of significant limitations for use in tracking tobacco users.

PL: Pub.L. 111 - 31 201 Name of Law: Tobacco Control Act

Not associated with rulemaking

  83 FR 53485 10/23/2018
84 FR 22862 05/20/2019

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 15,602 27,935 0 0 -12,333 0
Annual Time Burden (Hours) 3,340 4,435 0 0 -1,095 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
FDA is requesting an extension on the currently approved information collection request for remaining planned studies, panel maintenance and replenishment activities and non-substantive changes to update the estimated burden for an additional year of panel replenishment. The average annual burden hours will increase by 1,699 hours, from 4,435 to 6,134 hours.

Yes Part B of Supporting Statement
Amber Sanford 301 796-8867 [email protected]


On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

© 2024 | Privacy Policy